Wang Xuyi and Wang Juelu contributed equally to this work.
Phase I study of injectable, depot naltrexone for the relapse prevention treatment of opioid dependence
Article first published online: 20 SEP 2013
Copyright © American Academy of Addiction Psychiatry
The American Journal on Addictions
Volume 23, Issue 2, pages 162–169, MarchߝApril 2014
How to Cite
Xuyi, W., Juelu, W., Xiaojun, X., Haiyan, L., Zheyuan, L., Zhehui, G., Guoming, D., Gang, L., Jin, L. and Wei, H. (2014), Phase I study of injectable, depot naltrexone for the relapse prevention treatment of opioid dependence. The American Journal on Addictions, 23: 162–169. doi: 10.1111/j.1521-0391.2013.12085.x
- Issue published online: 7 FEB 2014
- Article first published online: 20 SEP 2013
- Manuscript Accepted: 31 MAR 2013
- Manuscript Revised: 27 MAR 2013
- Manuscript Received: 26 OCT 2012
- National Key Basic Research and Development Program (NKBRDP) of China. Grant Number: 2009CB522000
- National Nature Science Foundation. Grant Number: 30971050
Options for accessing this content:
- If you are a society or association member and require assistance with obtaining online access instructions please contact our Journal Customer Services team.
- If your institution does not currently subscribe to this content, please recommend the title to your librarian.
- Login via other institutional login options http://onlinelibrary.wiley.com/login-options.
- You can purchase online access to this Article for a 24-hour period (price varies by title)
- New Users: Please register, then proceed to purchase the article.
Login via OpenAthens
Search for your institution's name below to login via Shibboleth.
Registered Users please login:
- Access your saved publications, articles and searches
- Manage your email alerts, orders and subscriptions
- Change your contact information, including your password
Please register to:
- Save publications, articles and searches
- Get email alerts
- Get all the benefits mentioned below!
Patients and/or caregivers may access this content for use in relation to their own personal healthcare or that of a family member only. Terms and conditions will apply.